These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1624391)

  • 1. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M; Noji Y; Iwahi T; Yamazaki T
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus.
    Hayes MV; Orr DC
    J Antimicrob Chemother; 1983 Aug; 12(2):119-26. PubMed ID: 6413485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.
    Pucci MJ; Boice-Sowek J; Kessler RE; Dougherty TJ
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2312-7. PubMed ID: 1804003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli.
    Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ
    J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa.
    Masuyoshi S; Inoue M; Takaoka M; Mitsuhashi S
    Arzneimittelforschung; 1981; 31(7):1070-2. PubMed ID: 6268122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ; Traynor EA; Griggs DJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of KP-736, a new cephem antibiotic.
    Maejima T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):104-10. PubMed ID: 2014964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
    Hashizume T; Nakamura K; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):139-42. PubMed ID: 9099223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin.
    Mochizuki H; Oikawa Y; Yamada H; Kusakabe S; Shiihara T; Murakami K; Kato K; Ishiguro J; Kosuzume H
    J Antibiot (Tokyo); 1988 Mar; 41(3):377-91. PubMed ID: 3130365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R; Andrews JM; Cross C; Piddock LJ
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity.
    Watanabe N; Katsu K
    J Antibiot (Tokyo); 1993 Nov; 46(11):1707-15. PubMed ID: 8270493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity of cefoperazone for penicillin-binding proteins.
    Matsubara N; Minami S; Matsuhashi M; Takaoka M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):195-9. PubMed ID: 6448021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activities of DQ-2556 and its mode of action.
    Tanaka M; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2595-601. PubMed ID: 1482128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.
    Sumita Y; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 Mar; 43(3):314-20. PubMed ID: 2108953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli.
    Hashizume T; Ishino F; Nakagawa J; Tamaki S; Matsuhashi M
    J Antibiot (Tokyo); 1984 Apr; 37(4):394-400. PubMed ID: 6427167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the bacteriolytic and biochemical properties of ceftiolene (42980RP).
    Williamson R; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1984 Dec; 14(6):581-93. PubMed ID: 6394571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-binding protein inactivation by human neutrophil myeloperoxidase.
    Rakita RM; Rosen H
    J Clin Invest; 1991 Sep; 88(3):750-4. PubMed ID: 1653273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N; Katsu K; Moriyama M; Kitoh K
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
    J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.